研究目的: This is a Phase 1 trial to investigate the safety and efficacy of the investigational drug, DCC-2618, administered orally (PO), in adult patients with advanced malignancies.
赞助商: Deciphera Pharmaceuticals LLC
试用版联系方式: Divya Sakamuri; 1-713-745-3296; dsakamuri@mdanderson.org or Filip Janku; 713-563-1930; FJanku@mdanderson.org
要求患者参与: ECD patients 18 years or older.
已知参与该试验并接收ECD患者的中心: MD安德森癌症中心,德克萨斯州休斯顿市
ClinicalTrials.gov 标识符: NCT02571036

